P223Facing up the problem of no need for routine laboratory monitoring of new oral anticoagulants (direct thrombin inhibitors, direct factor Xa inhibitors)
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
D Kuleshova, AG Obrezan. "P223Facing up the problem of no need for routine laboratory monitoring of new oral anticoagulants (direct thrombin inhibitors, direct factor Xa inhibitors)." Cardiovascular Research 103.suppl 1 (2014) S39.4-S40